干细胞培养中的新发现

在培养人胚胎干细胞时需使用小鼠血清成分作为滋养元素,如果撤除小鼠血清成分,干细胞就会从干细胞状态变为分化状态。这些小鼠血清成分有可能对分化的组织器官造成污染,从而引起免疫排斥。生物学家数年来一直寻找不使用小鼠成分的培养条件保持人胚胎干细胞非分化状态。今年,美国威斯康辛的科学家,徐和James Thomson等(James Thomson是第一个成功分离人胚胎干细胞的科学家)发现用人工合成的成纤维生长因子2就可以保持人胚胎干细胞处于不分化状态。成纤维生长因子2是通过抑制骨髓多形遗传蛋白(这是一种促干细胞分化的分子)起作用的。     

三疣梭子蟹不同组织同工酶的分析

采用垂直板状聚丙烯酰胺凝胶电泳技术 ,分析了三疣梭子蟹 (Portunustriuberbuculatus)雌性成体心脏、鳃、肌肉、眼睛、肝胰腺和卵巢 6种组织中的 1 0种同工酶 (ADH、MDH、ME、LDH、α AMY、GDH、SOD、SDH、EST和GOT)的分化表达模式 ,并对各种酶的同工酶位点表达及酶谱表型进行了分析。结果显示 ,三疣梭子蟹的同工酶系统具有明显的组织特异性。     

促细胞黏附生长的自组装肽水凝胶

随着细胞与组织工程的迅猛发展,能够促进细胞黏附、生长和分化的生物材料基质支架的研究日益重要。具有生物相容性且含水量超过99％的自组装肽水凝胶因其很好地符合理想的生物材料基质支架标准而备受重视。这类自我互补的两亲寡肽含50％的带电残基,并且以交替的离子亲水性和不带电的氨基酸残基周期性重复为特征;在其寡肽的氨基末端可用直接固相合成法修饰几个短序列生物活性模体进行功能化,用以促进不同细胞的黏附生长和靶向定位。现对自组装肽水凝胶的结构特征、自组装机制、对细胞黏附生长的影响以及未来自组装肽生物材料设计的目标进行综述．     

生长激素受体及其介导的信号转导

生长激素受体(growth hormone receptor,GHR)是细胞因子／造血因子受体超级家族的一员。它通过二聚体的形式和生长激素(growth hormone,GH)相结合,然后诱发Janus激酶2(Janus kinase 2,JAK2)等细胞因子酪氨酸磷酸化并通过4条不同的途径将信号传入细胞内从而产生一系列的生理效应。现在了解GHR的结构特征、组织分布的基础上,对其介导的信号转导途径作进一步的阐明。     

主要组织相容性复合体I类分子抗原肽

被主要组织相容性复合体(MHC)I类分子呈递在细胞表面的抗原肽大部分来源于细胞内新合成蛋白质的降解产物,抗原肽直接体现细胞内功能蛋白质的部分变化,蛋白酶体、氨肽酶和抗原转运体(TAP)参与调控抗原肽的生成。在MHC的组装、折叠过程中,抗原肽促进各亚基的结合和折叠进程;而在起始细胞的免疫应答过程中,抗原肽不仅诱导T细胞抗原受体的特异结合,更为重要的是延长MHC同T细胞抗原受体特异结合的作用时间。     

PEG对甘薯愈伤组织淀粉酶活性的影响

用聚乙二醇 (PEG) 6 0 0 0对甘薯愈伤组织进行处理后观察到其所含淀粉酶的活性变化。这些变化随PEG的浓度不同 ,处理时间长度不同而有显著差异。低浓度的PEG(0 5 %、 1% )处理愈伤组织其淀粉酶活性变化的幅度较小 ;而高浓度 (8% )的PEG处理所引起的淀粉酶活性变化幅度较大 ;这一结果显示了PEG对甘薯愈伤组织淀粉酶的调节作用。     

cis基因交换形成RHD-CE(2-9)-D等位基因

以往通过基因组DNA分析,分别在高加索人和中国人中观察到少数Rh阴性个体存在RHD基因第1和第10外显子,但是该等位基因形成的具体分子机制尚有争论。本文分别针对RHD基因mRNA的5′-和3′-非编码区设计一对特异性引物,通过逆转录PCR（RT-PCR）和cDNA测序,分析2例RHD基因阳性（拥有第1和第10外显子）、D抗原表型阴性个体的全长mRNA/cDNA序列,同时以1例正常Rh阳性个体（CcDDee）作对照。结果正常Rh阳性个体拥有正常RHD基因mRNA,2名携带RHD基因的Rh阴性个体则均检出存在与正常RHD基因或RHCE基因转录产物相同长度、以及相同外显子构成的mRNA,但该转录子的第1和第10外显子及3′-非编码区序列与RHD基因一致,而第2～9外显子全部序列与RHCE(e)基因mRNA相同,表明2名个体均存在RHD-CE(2~9)-D融合RHD等位基因,即其RHD基因的第2～9外显子被同源RHCE(e)基因替换,导致不能编码正常RhD蛋白,形成个体D抗原阴性表型。     

人新基因hbrp的染色体定位及其对TPK活性的抑制作用（简报）

hbrp(Human BSP-Related Protein)是我们实验室最近在睾丸组织中克隆的一个人与BSP（bovine seminal plasma)蛋白相关的新基因。为了将有关该新基因信息与现有人类基因组转录图相整合,我们应用荧光原位杂交(fluorescent in situ hybridizationFISH)法进行了该基因的人染色体基因定位,结果成功地将hbrp基因定位在人19号染色体长臂1区3带上。hbrp基因是在对BSP蛋白功能的研究过程中发现并克隆的,其同源性分析发现,与其序列最相近     

GFP-mTn融合蛋白对蓝猪耳生活细胞微丝骨架的标记

用农杆菌介导法将嵌合基因GFP-mTn(mTn是微丝结合蛋白Talin的微丝结合域,可以显示活体细胞中微丝的结构)导入蓝猪耳。经激光共聚焦显微镜观察了转基因植株的各种不同组织中融合蛋白的表达和分布情况。在叶片的表皮细胞、保卫细胞、根部的皮层细胞中有融合蛋白的不同程度表达。但仅在保卫细胞中微丝标记状况良好,显示基因表达的组织特异性。经光诱导处于开放态的气孔的保卫细胞微丝呈网状结构,在细胞内无规则分布;经黑暗诱导处于关闭态的气孔保卫细胞中微丝束沿保卫细胞纵轴排列,呈卷曲状分布,并观察到螺旋和环状的微丝结构。在转基因植株的其他部位,例如茎表皮细胞、根毛细胞和花粉粒中,未检测到目的基因的表达。本研究获得的转基因植株为研究气孔运动过程中微丝动态变化提供了有用的材料。     

中国人胃癌染色体17q21区域基因遗传不稳定性研究

To investigate microsatellite instability (MSI) and loss of heterozygosity (LOH) of locus D17S396, D17S579 and D17S855, and their effect on the expression of nm23H1 and BRCA1 of gastric cancer, which would provide experimental basis for clinical treatment and prognosis analysis of gastric cancer. DNA was extracted from paraffin-embedded materials. Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) was used to analyze MSI and LOH. Expression of nm23H, and BRCA1 was detected by Envision immuno-histochemistry and Leica-Qwin computer imaging techniques. In the forty cases of gastric cancer, the frequency of MSI, LOH and nm23H1 protein were 20.00%, 17.50% and 55.00% respectively at locus D17S396, while at locus D17S579, the frequency of MSI, LOH and BRCA1 protein were 22.50%, 15.00% and 37.50% respectively; at locus D17S855, the frequency of MSI, LOH and BRCA1 of thirty-seven cases were 18.92%, 18.92%, 37.84% respectively. In tumor node metastasis (TNM) staging, at locus D17S396, D17S579 and D17S855, MSI in stages I + II appeared more frequently than that in stages III + IV, while LOH appeared the contrary tendency. In the group of metastasis of gastric cancer, MSI had a less frequency (5.00%) than that with no metastasis (35.00%, P < 0.05) at locus D17S396, but LOH appeared more frequently (30.00%) than that with no metastasis (5.00%, P < 0.05). At locus D17S579, MSI had an increasing tendency with the degree of tumor differentiation (50.00% in high differentiation cases, 20.00% in middle differentiation cases, and 0% in low differentiation cases, P < 0.05). The frequency of nm23H1 and BRCA1 protein in stages TNM I + II was higher than that in stages TNM III + IV; and that in higher differentiation cases was higher than in poor differentiation cases. The frequency of nm23H1 protein in the group of metastasis (30.00%) was less than that with no metastasis significantly (80.00%, P<0.01). The frequency of nm23H1 protein in the group positive to MSI (87.50%) was higher than that in the group negative to MSI (46.88%, P < 0.05). However, nm23H1 protein in group positive to LOH (14.29%) was lower than that in the group negative to LOH (63.64%, P < 0.05). The frequency of BRCA1 protein in the group positive to MSI (66.67%) was more than that in the group negative to MSI (29.03%, P < 0.05). The results of experiments indicate that MSI and LOH may separately control the development of sporadic colon cancer with different pathways. MSI may be an early period molecule marker for sporadic colon cancer, enhanced expression of nm23H1 protein can effectively inhibit colon cancer metastasis and improve prognosis of sporadic colon cancer patients. By comparison, LOH mostly arises in the late period of sporadic colon cancer and endows a high aggressive and poor prognostic phenotype. nm23H1 protein could effectively restrain gastric cancer metastasis and development; and BRCA1 protein could restain tumor from becoming lower differentiation.